342 related articles for article (PubMed ID: 11907201)
1. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
3. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.
Geiss BJ; Smith TJ; Leib DA; Morrison LA
J Virol; 2000 Dec; 74(23):11137-44. PubMed ID: 11070010
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice.
Keadle TL; Laycock KA; Morris JL; Leib DA; Morrison LA; Pepose JS; Stuart PM
J Gen Virol; 2002 Oct; 83(Pt 10):2361-2365. PubMed ID: 12237416
[TBL] [Abstract][Full Text] [Related]
5. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.
Reszka NJ; Dudek T; Knipe DM
Vaccine; 2010 Mar; 28(15):2754-62. PubMed ID: 20117270
[TBL] [Abstract][Full Text] [Related]
6. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Morrison LA; Knipe DM
J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
8. Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.
Richards CM; Case R; Hirst TR; Hill TJ; Williams NA
J Virol; 2003 Jun; 77(12):6692-9. PubMed ID: 12767989
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
Morrison LA; Knipe DM
Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.
Smith TJ; Ackland-Berglund CE; Leib DA
J Virol; 2000 Apr; 74(8):3598-604. PubMed ID: 10729135
[TBL] [Abstract][Full Text] [Related]
12. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
Matundan H; Mott KR; Ghiasi H
J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease.
van Lint AL; Torres-Lopez E; Knipe DM
Virology; 2007 Nov; 368(2):227-31. PubMed ID: 17915278
[TBL] [Abstract][Full Text] [Related]
14. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
Augustinova H; Hoeller D; Yao F
J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
[TBL] [Abstract][Full Text] [Related]
15. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
[TBL] [Abstract][Full Text] [Related]
16. ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice.
Korom M; Wang H; Bernier KM; Geiss BJ; Morrison LA
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515256
[TBL] [Abstract][Full Text] [Related]
17. Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice.
Walker J; Laycock KA; Pepose JS; Leib DA
Vaccine; 1998 Jan; 16(1):6-8. PubMed ID: 9607002
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice.
Keadle TL; Laycock KA; Miller JK; Hook KK; Fenoglio ED; Francotte M; Slaoui M; Stuart PM; Pepose JS
J Infect Dis; 1997 Aug; 176(2):331-8. PubMed ID: 9237697
[TBL] [Abstract][Full Text] [Related]
19. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
20. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI
J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
